Through faster, less labor intensive processing of tumor biopsies and other specimens, SynderBio’s technology will benefit researchers, clinicians, pathologists, and patients. Faster, more consistent tissue preparation means lower and more predictable cost to pathology laboratory, and faster diagnosis and treatment for patients.